Doctoral program extended at St. Louis College of Pharmacy
ST. LOUIS — St. Louis College of Pharmacy is extending its doctor of pharmacy program to span seven years.
Beginning in the 2014 academic year, the program — which currently is six years for students — will allow students to achieve a bachelor of science degree after four academic years and also will provide opportunities for electives and time for patient-centered and interprofessional initiatives, according to the St. Louis Business Journal.
In June 2011, St. Louis College of Pharmacy launched a strategic plan called STLCOP 20/20, which is designed to help the school "strive to diversify [our] academic offerings; advance a community-centered research and scholarship agenda; establish economically sustainable pharmacy practice models; ensure that personal and professional growth is a hallmark of the STLCOP community; and reach beyond [our] campus to impact [our] communities in innovative ways."
Click here for the full report.
Mead Johnson sets succession plan in motion as CEO announces retirement
GLENVIEW, Ill. — Mead Johnson Nutrition on Friday announced that the company’s president and CEO, Steve Golsby, will retire by the 2013 annual meeting of stockholders. Mead Johnson’s board selected Kasper Jakobsen, EVP and COO, to serve as CEO-elect.
Jakobsen is expected to succeed Golsby as Mead Johnson Nutrition president and CEO upon Golsby’s retirement, the company said. Jakobsen will continue in his role as COO, and the current senior leadership structure and reporting relationships will remain in effect.
"As Steve’s replacement, Kasper Jakobsen has the confidence of the full Board, reflecting his experience as a 14-year veteran of Mead Johnson, including operational leadership responsibility for the businesses in Asia, North America and Latin America prior to becoming executive vice president and chief operating officer earlier this year," Mead Johnson chairman Jim Cornelius said.
Walgreens to extend Well Experience flagship into downtown Philly
PHILADELPHIA — Downtown Philadelphia will be the site for Walgreens’ next Well Experience flagship store, according to an online report published Friday by CBS/Philly. The new Walgreens will be located at Broad and Chestnut Streets in Center City, filling the space of what was once a Borders bookstore.
The retail space extends 26,000 sq. ft. across three floors.
The CBS/Philly report suggested the new store will open its doors this fall, citing the real estate agent who brokered the deal.
Walgreens Well Experience flagship stores currently are located in Chicago, Las Vegas, New York and Washington, D.C. In addition to this one in Philadelphia, two more are planned for Los Angeles and Boston, according to published reports.
"It’s clear we’re stepping out of the traditional drug store format to create something completely new and unique," Walgreens president and CEO Greg Wasson shared with investors in March. "We’re combining cutting-edge design with an improved product assortment and developing the right mix of health care, beauty, fresh food and private brand solutions to more closely meet the needs of our communities. Our goal is to create an experience unmatched in the industry and one that is flexible enough to accommodate every community. From a store in an urban food desert to suburban stores to a flagship location on Wall Street and all types in between," he said. "The response we’re gaining from customers, payers, government officials and employees is extremely encouraging. Our most impressive leading indicator is customer delight, the metric we use to measure customer reaction. We’ve seen a significant jump in the last 6 months in both pharmacy and front end that reflects our enhanced in-store experience."